Survivorship research established investigator award

描述(由申请者提供)：这项资助的具体目标是指导年轻的临床研究人员，主要是在与癌症症状控制和/或癌症治疗相关的研究领域。在调查员的职业生涯中，有一段时间，以前接受过指导的人成为了导师。尽管承认这一点可能并不容易，但在我职业生涯过半的时候，我已经从最初的导师转变为一名导师。我目前是北中癌症治疗小组(NCCTG)癌症控制项目主任，也是梅奥诊所综合癌症中心癌症预防和控制项目的联席主任。十多年来，我一直担任社区临床肿瘤学计划(CCOP)研究基础拨款的首席研究员，并在过去获得过R01拨款。通过这一努力，我可以说开发了世界上最有成效的计划，旨在评估缓解癌症和/或癌症治疗引起的症状的方法。利用这一背景，我将利用从这笔赠款中获得的资金，为有兴趣从事与缓解癌症症状和/或癌症治疗相关的临床研究的年轻临床研究人员提供指导。我将使用“在职”培训的方法来帮助他们制定适用的协议。我将通过方案审查过程，通过进行临床试验，并通过以科学摘要和手稿的形式报告结果的过程来指导他们。我将协助他们领导梅奥肿瘤学症状控制计划的各个部分。我将帮助他们发展独立的赠款资金。我认为这是一个继任规划的过程，希望这些接受指导的人中有一人或多人最终会接替我的位置，继续公布我们在梅奥诊所的症状控制研究计划，让他们能够指导下一代研究人员。作为导师的这一角色使我能够回馈科学领域一些在我职业生涯早期提供给我的导师的成果。这应该允许继续研究缓解癌症和/或癌症治疗相关症状的有希望的方法。这将改善对癌症患者的护理。

DESCRIPTION (provided by applicant): The specific aim of this grant is to mentor young clinical investigators, primarily in the area of research related to the control of symptoms caused by cancer and/or cancer therapy. A time comes in an investigator's career when a previously mentored person becomes the mentor. Although it might not be easy to admit, being more than half way through my career, I have made the transformation from primarily being mentored, to being a mentor. I am currently the Director of the Cancer Control Program of the North Central Cancer Treatment Group (NCCTG) as well as the co-director of the Cancer Prevention and Control Program of the Mayo Clinic Comprehensive Cancer Center. I have been the Principal Investigator of a community clinical oncology program (CCOP) research base grant for over a decade and have received R01 grant funding in the past. Through this effort, I have, arguably, developed the most productive program in the world designed to evaluate means of alleviating symptoms caused by cancer and/or cancer therapy. Using this background, with the funds obtained from this grant I will provide mentorship for young clinical investigators interested in a career in clinical research related to relief of symptoms from cancer and/or cancer therapy. I will use an "on-the-job" training approach to help them with the development of applicable protocols. I will mentor them through the protocol review process, through the conduct of clinical trials, and through the process to report results as scientific abstracts and manuscripts. I will facilitate their leadership of subsections of the Mayo Oncology Symptom Control Program. I will facilitate their development of independent grant funding. I view this as a process of succession planning, expecting that one or more of these mentored individuals will eventually take my place and continue to promulgate the symptom control research program that we have at Mayo Clinic, allowing them to mentor the next generation of investigators. This role as a mentor allows me to give back to the scientific field some of the fruits from the mentoring that was provided to me in my early career. This should allow for continued investigation for promising means for alleviating symptoms related to cancer and/or cancer therapy. This will improve the care of patients with cancer.